Evidence map›Paper›PMID 32292352›Full record

ArticleFrontiers in physiology2020

Slit2 Protects Hearts Against Ischemia-Reperfusion Injury by Inhibiting Inflammatory Responses and Maintaining Myofilament Contractile Properties.

Xiang Li, Shuang Zheng, Weijiang Tan, Hongqi Chen, Xiaohui Li, Jian Wu, Ting Luo, Xuecong Ren, W Glen Pyle, Lijing Wang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. SLIT2 as a key regulator and therapeutic target in liver injury.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Xiang LiGuangdong Province Key Laboratory of Laboratory Animals, Cardiovascular Model Research Center, Guangdong Laboratory Animals Monitoring Institute, Guangzhou, China.
Shuang ZhengGuangdong Province Key Laboratory of Laboratory Animals, Cardiovascular Model Research Center, Guangdong Laboratory Animals Monitoring Institute, Guangzhou, China.
Weijiang TanGuangdong Province Key Laboratory of Laboratory Animals, Cardiovascular Model Research Center, Guangdong Laboratory Animals Monitoring Institute, Guangzhou, China.
Hongqi ChenGuangdong Province Key Laboratory of Laboratory Animals, Cardiovascular Model Research Center, Guangdong Laboratory Animals Monitoring Institute, Guangzhou, China.
Xiaohui LiDepartment of Cardiovascular Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, China.
Jian WuShanghai Institute of Cardiovascular Diseases, Zhongshan Hospital and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Ting LuoGuangdong Province Key Laboratory of Laboratory Animals, Cardiovascular Model Research Center, Guangdong Laboratory Animals Monitoring Institute, Guangzhou, China.
Xuecong RenGuangdong Province Key Laboratory of Laboratory Animals, Cardiovascular Model Research Center, Guangdong Laboratory Animals Monitoring Institute, Guangzhou, China.
W Glen PyleDepartment of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada.
Lijing WangSchool of Basic Medicine, Vascular Biology Institute, Guangdong Pharmaceutical University, Guanghzou, China.
Peter H BackxDepartment of Biology, York University, Toronto, ON, Canada.
Ren HuangGuangdong Province Key Laboratory of Laboratory Animals, Cardiovascular Model Research Center, Guangdong Laboratory Animals Monitoring Institute, Guangzhou, China.
Feng Hua YangGuangdong Province Key Laboratory of Laboratory Animals, Cardiovascular Model Research Center, Guangdong Laboratory Animals Monitoring Institute, Guangzhou, China.
Guangdong Laboratory Animals Monitoring Institute · CNFirst Affiliated Hospital of Jinan University · CNGuangdong Pharmaceutical University · CNSun Yat-sen University · CNUniversity of Guelph · CAYork University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe secreted glycoprotein Slit2, previously known as an axon guidance cue, has recently been found to protect tissues in pathological conditions; however, it is unknown whether Slit2 functions in cardiac ischemia-reperfusion (IR) injury.

methodsLangendorff-perfused isolated hearts from Slit2-overexpressing (Slit2-Tg) mice and C57BL/6J mice (background strain) were subjected to 20 min of global ischemia followed by 40 min of reperfusion. We compared Slit2-Tg with C57BL/6J mice in terms of left ventricular function and infarct size of post-IR hearts along with tissue histological and biochemical assessments (mRNA and protein expression, phosphorylation status, and myofilament contractile properties).

resultsSlit2 played cardioprotective roles in maintaining contractile function and reducing infarct size in post-IR hearts. IR increased the expression of the Slit2 receptor Robo4 and the membrane receptor Slamf7, but these increases were suppressed by Slit2 overexpression post IR. This suppression was associated with inhibition of the nuclear translocation of NFκB p65 and reductions in IL-1β and IL-18 release into perfusates. Furthermore, Slit2 overexpression attenuated the increases in myofilament-associated PKCs and phosphorylation of cTnI at Ser43 in the post-IR myocardium. The myofilament calcium sensitivity and actomyosin MgATPase activity were preserved in the post-IR Slit2 myocardium.

conclusionOur work demonstrates that Slit2 inhibits inflammatory responses and maintains myofilament contractile properties, thus contributing, at least in part, to the prevention of structural and functional damage during IR.

Indexed as

contractile functioncTnIinflammatory responseischemia-reperfusion injurymyofilament phosphorylationprotein kinase CRNA sequencingSlit2

Identifiers

PMID32292352
PMCPMC7135862
OpenAlexW3014052441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.